Stevanato Group to Present at Upcoming Investor Conferences

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in two upcoming investor conferences.

The Company will present at the William Blair Growth Stock Conference in Chicago on Tuesday, June 4, 2024 at 4:00 p.m. (CT), and at the Jefferies Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:30 a.m.(ET). A live webcast of each event will be available on the Company’s website at www.stevanatogroup.com under the "Investors" section. Replays of the webcasts will be available for approximately 90 days after each event.

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.

For more information, please visit www.stevanatogroup.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240523189979/en/

Media
Stevanato Group
[email protected]

Investor Relations
Lisa Miles
[email protected]

Source: Stevanato Group S.p.A.

You May Also Be Interested In

• Fortitude Provides Second Quarter 2026 Financial and Operating Highlights
• Granite Asia Ranked No. 1 Top Private Equity Firm in Asia Among Singapore’s Leading Financial Firms, Independent Research Finds
• Genius Dog Launches First-Ever Birthday Box for Dogs on Chewy